Henry Byabajungu

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Rifampicin susceptibility discordance between Xpert MTB/RIF G4 and Xpert Ultra before MDRT-TB treatment initiation: A case report from Uganda”.

Rifampicin susceptibility discordance between Xpert MTB/RIF G4 and Xpert Ultra before MDRT-TB treatment initiation: A case report from Uganda

Journal of Clinical Tuberculosis and Other Mycobacterial Diseases(2021)10.1016/j.jctube.2021.100286

N/A

0DataRank · unranked

0 citations

Kevin Komakech, Sharon Namiiro, Henry Byabajungu, Joanitah Nalunjogi, Winceslaus Katagira +7 more

First report of whole-genome analysis of an extensively drug-resistant Mycobacterium tuberculosis clinical isolate with bedaquiline, linezolid and clofazimine resistance from Uganda

Antimicrobial Resistance and Infection Control(2022)10.1186/s13756-022-01101-2

N/A

0DataRank · unranked

28 citations

Joel Kabugo, Francis Kakooza, Isa Adam, Ocung Guido, Henry Byabajungu +15 more

Molecular characterisation of second-line drug resistance among drug resistant tuberculosis patients tested in Uganda: a two and a half-year’s review

BMC Infectious Diseases(2022)10.1186/s12879-022-07339-w

N/A

0DataRank · unranked

12 citations

Dianah Linda Kasemire, Ivan Ibanda, Joel Kabugo, Andrew Nsawotebba, Jody Phelan +11 more